mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.8 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.8 |
mRNA |
PF-4708671 |
GDSC1000 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.8 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |